Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT [PDF]
, 2011 Alexandra D Jensen +8 more
openalex +1 more source
Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics [PDF]
, 2018 Purpose: It is generally assumed that the biodistribution and pharmacokinetics of radiolabelled antibodies remain similar between dosimetric and therapeutic injections in radioimmunotherapy.
Antonescu, Cristian +9 more
core
Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin’s lymphoma
Exploration of Targeted Anti-tumor TherapyRadioimmunotherapy (RIT) is a therapy that combines a radioactive nucleotide with a monoclonal antibody (mAb). RIT enhances the therapeutic effect of mAb and reduces toxicity compared with conventional treatment.
Hiroki Goto +2 more
doaj +1 more source
Experimental study of radioimmunotherapy versus chemotherapy for colorectal cancer [PDF]
, 2010 Gabie M. de Jong +5 more
openalex +1 more source
Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model [PDF]
, 2015 Nolwenn Fichou +11 more
openalex +1 more source
Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration [PDF]
, 2023 Ashleigh Hull +5 more
openalex +1 more source
Development of Zevalin and future prospect of radioimmunotherapy
, 2013 Masahiko Tokura, Yoshifumi Yabuuchi
openalex +2 more sources